| 1 | LLY | Eli Lilly and Company | 10.10% |
| 2 | RHHBY | Roche Holding AG | 4.49% |
| 3 | LON: AZN | AstraZeneca PLC | 4.20% |
| 4 | UNH | UnitedHealth Group Incorporated | 4.19% |
| 5 | ABT | Abbott Laboratories | 3.69% |
| 6 | GILD | Gilead Sciences, Inc. | 3.62% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.50% |
| 8 | BSX | Boston Scientific Corporation | 3.19% |
| 9 | JNJ | Johnson & Johnson | 3.04% |
| 10 | MDT | Medtronic plc | 3.01% |
| 11 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.98% |
| 12 | ABBV | AbbVie Inc. | 2.96% |
| 13 | SWX: NOVN | Novartis AG | 2.88% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.76% |
| 15 | DHR | Danaher Corporation | 2.65% |
| 16 | MRK | Merck & Co., Inc. | 2.50% |
| 17 | CPH: NOVO.B | Novo Nordisk A/S | 2.35% |
| 18 | REGN | Regeneron Pharmaceuticals, Inc. | 2.24% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 2.21% |
| 20 | AMGN | Amgen Inc. | 2.11% |
| 21 | RVMD | Revolution Medicines, Inc. | 2.10% |
| 22 | CYTK | Cytokinetics, Incorporated | 1.90% |
| 23 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.86% |
| 24 | BMY | Bristol-Myers Squibb Company | 1.83% |
| 25 | MCK | McKesson Corporation | 1.82% |
| View HRTS holdings |
